Ryohin Keikaku7453 JT
The margin recovery is real — gross margin rebuilt to 52.4%, operating margin from a 5.7% trough back to 10.3% — and the multiple has returned to a decade high to pay for it. Valued region by region on a normalised, FX-neutral margin, the sum lands roughly a third below the spot. This is genuine operating quality carried at the price of its own bull case, on a stock that has purged exactly this configuration twice before.
East Asia, at ¥32.9bn of normalised segment operating profit net of corporate on the 21x multiple its 20% margin and its growth earn, is worth roughly ¥691bn — 58% of the reconstructed enterprise value on 31% of the revenue.
Japan adds ¥390bn at 13x ; SE Asia and Europe & Americas add ¥119bn between them. The gross regional sum reconstructs to about ¥1,199bn of enterprise value.
Net cash brings equity to ¥1,224bn — ¥2,305 per share on the net-of-treasury count of 530.83m. The normalised P/E anchor lands at ¥2,440, and the two methods converge on ¥2,350–2,450.
The market capitalises Ryohin at ¥1,919bn, an enterprise value near ¥1,895bn. The reconstruction sits roughly a third below the price, and it takes a peak-cycle 25x blended multiple to close the gap.
The interesting thing about Ryohin Keikaku is that the debate everyone is having — is the margin recovery real? — is the wrong one, because the answer is yes. Gross margin has been rebuilt from a 46.7% trough in FY August 2023 to 52.4% in the first half of FY August 2026, without losing volume ; the operating margin has climbed from 5.7% to 10.3% over the same window. The company attributes the lift to bringing more of its production in-house and to tighter markdown discipline, and both are real operating levers rather than accounting. So the recovery is genuine and well executed. The question the dossier actually turns on is narrower and more awkward : what does the price have to assume to be right, and is it assuming too much at once?
What the multiple encodes is not one bet but three, held simultaneously. A current-FY P/E near 30.7x and a price-to-book of 5.1x — back at a decade high — require an operating margin that stays durably above 10%, an East Asia engine that keeps compounding double-digits, and no reversal from either the residual FX flatter in the margin or the excess inventory sitting on the balance sheet. Each is defensible on its own. The difficulty is that the price needs all three to hold together, and it treats a decade-high multiple as a floor when the ten-year average price-to-book is 3.3x.
This is also the one name in the bucket whose own history is the strongest argument against extrapolating it. The multiple has round-tripped 4.4x to 1.4x to 5.1x on a book that compounded steadily throughout — the shares behave as a barometer of sector risk appetite rather than a read on quality. In 2018 the market let the same price-to-book reach 5.65x on a China-optionality narrative before the margin turned, and the stock then took the worst relative drawdown in the universe, −53.5%. The configuration on offer today — decade-high multiple, margin near its cyclical peak, one concentrated engine — is the one this specific stock has already unwound twice.
None of that makes it a short. Once the discount rate is corrected to a credible ~7% — the live 10.64% carries an implied equity risk premium of ~11.2%, which no developed market supports — the return on capital ex-cash of 17.1% clears its cost by about 10 points. That is a wide risk-adjusted spread, wider than the sector work credited on the inflated rate, and a compounder earning it is a stock to own at a better price, not to fade at a decade top. The balance sheet is a fortress, the governance is the cleanest in the bucket, and the Credit Saison overhang has been cleared.
The position framing is patient observation, not ownership at this level. The weighted asymmetry is materially negative and there is no margin of safety in the price. Conviction is moderate-to-strong on the direction. The entry is a de-rating toward roughly ¥2,600, or a sustained operating margin at or above 11% across the full FY August 2026 and FY August 2027 prints — either would re-qualify the plateau as structural. Both are observable on the published calendar.
The cleanest way to read the decade is as one full margin cycle laid over a revenue line that never broke stride. Revenue compounded at roughly 11% a year without a serious interruption, from ¥259.7bn to ¥784.6bn, while the operating margin traced a complete arc : ~12% at the prestige peak of February 2018, down to 5.7% at the August 2023 trough, back to 10.3% in the latest half. The top line was never the problem ; the margin always was. Muji makes and gives back its economics through the margin, and the margin is driven by China and by inventory — which is exactly why any valuation anchored on a ten-year-average multiple is meaningless here. The average sits in the middle of a round-trip the stock has already completed.
| Inflection | Feb 2015Pre-cycle | Feb 2018Prestige peak | Aug 2023Trough | Aug 2025Recovery | Aug 2026Guidance |
|---|---|---|---|---|---|
| Revenue (¥bn) | 259.7 | 378.8 | 581.4 | 784.6 | 887.0 |
| EBIT (¥bn) | 23.8 | 45.3 | 33.1 | 73.8 | 89.0 |
| EBIT margin | 9.2% | 12.0% | 5.7% | 9.4% | 10.0% |
| Gross margin | ~47% | 51.5% | 46.7% | 51.4% | 52.4%H1 |
| Return on capital | 12.9% | 17.6% | 6.9% | 12.8% | — |
| Net cash (¥bn) | 16.3 | 48.8 | 19.4 | 32.8 | maintained |
| EPS (¥, split-adj.) | 31.4 | 57.4 | 41.8 | 95.9 | 116.8 |
| Price-to-book | ~4.4x | 5.65x | 1.42x | — | 5.1xspot |
Source: Data pack 2026-07-04, split-adjusted (1:10 in 2019, 1:2 in 2025). EBIT = reported operating income (IS_OPER_INC). FY labels rewritten to close date : the Feb→Aug year-end change in 2020–21 excludes a ~6-month COVID-trough stub from the annual series, so the Aug-2023 figures follow the transition. Net cash narrows around FY Feb-2020 as lease capitalisation lifts gross debt.
Three management decisions explain the arc. Overstocking has been chronic and never solved — inventory grew 3.3x over the decade against 3.0x for sales, days of stock run near 155, the highest in the bucket, and roughly ¥5bn of Chinese inventory is judged excess ; markdowns of ¥3–5bn a year are the recurring cost. Capital allocation has been passive — permanent net cash, a 27% payout held for ten years including after the TSE reform, and not a single buyback — which dilutes the consolidated return on a balance sheet that ex-cash earns far more. And the 2018 episode, when the board let a China-optionality narrative carry the multiple to 5.65x before the margin was proven, produced the worst drawdown in the universe. That was destruction of shareholder value rather than of the business, and the current price-to-book of 5.1x is close enough to rhyme.
The engine only makes sense once you stop reading the consolidated line and look at the regions, because they are economically different businesses wearing one brand. On the certified first-half segment grid, East Asia earns a 20.3% segment margin, Europe & Americas 15.9%, SE Asia 14.7%, and Japan 11.3%. East Asia throws off 43% of the segment profit on 31% of revenue and sits nearly level with Japan in absolute profit — Muji has quietly become a Chinese bet reported by a Japanese issuer. A single group margin is the average of that dispersion, which is why one consolidated multiple is the wrong instrument and the sum has to be built region by region.
The monetisation story is where the price and the reality diverge. The recovered gross margin stacks three levers of unequal durability, and the market reads them as one. The first is genuine no-brand pricing power — gross margin rebuilt +5.7pt from the trough with volume rising +14.8% in the half, the only pure price effect in the bucket, anchored in the deepening of vertical integration. The second is the East Asia mix, each incremental yen of Chinese revenue arriving at 20% margin against 11% at home — real, but a function of China not relapsing. The third is a residual FX flatter of roughly 0.3–1pt, sitting in imported OEM cost of goods, that normalises away at ¥130 to the dollar. Only the first is structural without reservation ; the multiple capitalises all three as a single plateau.
The critical cost is double : imported OEM cost of goods carried on a global average-cost method, which lags the spot and is a tailwind now but turns to a headwind under the 2026 synthetic-fibre shock, and the markdown on inventory. Bringing production in-house is the structural lever that reduces the OEM dependence and holds the gross margin. The bottleneck, though, is working capital. At ~155 days of stock, each strong year of growth immobilises capital, and the published free-cash conversion of ~68% is closer to ~50% once leases are stripped out — the apparent edge is partly an artefact of capitalised lease amortisation flowing through depreciation. Inventory growing faster than sales is the one line that can undo the margin recovery in a single quarter, and it has grown every year the company has.
This pillar carries the thesis because it is what forbids the short. Return on capital ex-cash of 17.1% on a credible ~7% cost of capital is a spread of about 10 points — wider than the sector work credited on the 10.64% rate, which back-solves to an implausible ~11.2% equity risk premium and was rejected as a terminal rate. The model is asset-light, capex runs ~3% of sales, and it carries permanent net cash and no leverage, so the book compounds on retention times return without any financial engineering. The limits are two and they are why this is not an exceptional compounder : free-cash conversion is only ~50% once leases are stripped out, dragged by the inventory, and the dormant balance sheet is allocated passively. A wide, clean spread — earned, and un-levered.
The second cardinal because the whole asymmetry hangs on whether one demand stream holds. The base is real — repeat multi-category purchase across a semi-defensive staples core, beta 0.75, first-half growth of +14.8%. But the growth is fragile in specific ways. It is expansion-led, carried by a 1,460-store network opening net stores every year rather than purely organic ; it is concentrated, with 58% of operating profit riding on East Asia ; and the inventory growing faster than sales is a signal that demand may be over-estimated upstream. Against Pal, whose negative working capital and PAL CLOSET pre-order reduce markdown risk, Muji's demand is structurally less predictable. The staples base holds ; the growth leg depends on China not relapsing.
The no-brand pricing power is genuine and validated — gross margin +5.7pt without volume loss, the only pure price effect in the bucket. But the category is a contestable value-lifestyle space and the switching costs are light. Deep enough to price, not deep enough to lock.
The record is asymmetric. Production and margin execution is strong — the in-housing is a real, well-piloted gain. Against it : chronically weak stock discipline, passive capital allocation held through the TSE reform, and a history of letting the China narrative over-value the stock. The clean recent move is the full disposal of the cross-shareholdings.
The cleanest pillar and the cleanest in the bucket : no family control, 87% free float, ~34% foreign, an institutional board, and the Credit Saison overhang now lifted. The limit is the modest 0.9% yield and a capital return that lags TSE-era peers rather than leads them.
A real operational compounder, not a top-tier one, with a valuation-fragility overlay. The decisive pillar is the model — the recalibrated ~10-point spread that makes the quality genuine and rules out a short — while the mediocre cash conversion and passive allocation stop it short of exceptional. Above a value trap, below a quality compounder such as Food & Life (19–20/25). The grade is consistent with the read : the economics create value, and the price already capitalises it.
Is the margin plateau structural, or a cyclical peak the multiple has already paid for ?
East Asia : durable engine, or a concentration waiting to break ?
The camp long the stock sees a +23.3% engine at 20% margin as durable compounding that earns the premium. The concern is that 58% of operating profit rides on a single cyclical market, and the ~¥5bn of excess East Asia inventory reads as demand over-estimated upstream — a Chinese slowdown would compress the margin and the multiple at the same time. The 20% margin is also a profit before the corporate allocation of −30%, so the true pole margin is lower.
Does the dormant balance sheet ever get mobilised ?
The price assumes it does not — permanent net cash, a 27% payout, no buyback in a decade including after the TSE reform. Unlike Shimamura, whose ¥45.7bn buyback is already re-rating the book, Ryohin activates no capital-return lever, so the dormant cash dilutes the consolidated return and is never pre-priced. The optionality is real but undated, and it is the only support the multiple has that does not depend on the margin.
At ¥3,615 and ~30.7x current-FY earnings, with a price-to-book of 5.1x, the market is pricing all three levers held at once : a normalised operating margin durably at or above 10%, double-digit East Asia growth in perpetuity, and no FX normalisation. The stock is back at a decade high on every multiple axis, consistent with its role as the sector's risk-on barometer. The forward EV/EBITDA of ~15–16x — not the trailing 18.3x — is still above the 10–12x decade mean. There is no yield floor : free-cash yield is ~2.6%, ~1.9% once leases are stripped, so the stock has no support from cash return and rests entirely on the margin and the multiple. Valued region by region on a normalised margin, the sum reconstructs about a third below the price ; it takes a peak-cycle 25x blended multiple to justify the spot.
The COGS lag turns to a headwind under the 2026 fibre shock and East Asia inventory forces a markdown, pushing the operating margin below 9%. The barometer turns as it did in 2018–20, and the market de-rates the stock from its top through the decade mean price-to-book of 3.3x and below, on a depressed EPS near ¥92 at ~18x. This is a timing disappointment, reversible — the book compounds, the pricing power survives a low cycle — not a permanent loss, unless East Asia consumption reverses structurally.
Muji executes the guidance — revenue +13%, operating profit ¥89bn, margin 10.0% — the structural pricing holds, and East Asia grows double-digit while decelerating. The multiple refluxes from its top toward mean-plus-premium as the market normalises the FX and prices in the concentration. The regional sum of the parts delivers ~¥2,305 on normalised operating profit, the P/E anchor ~¥2,440, and the two converge on ¥2,350–2,450. The recovery is done ; the re-rating simply unwinds.
The un-priced levers fire together — operating margin at or above 12% as in-housing and markdown discipline hold, East Asia accelerates on share and new formats, a first buyback is announced, and the Europe scale-up lands. The multiple is held near 30x on an EPS around ¥120, price-to-book ~4.5x. The spot already capitalises this path, which is why the bull offers almost no return : the perfect outcome is the base case for the price.
| KPI | Latest value | Status | What it tells us |
|---|---|---|---|
| Consolidated operating margin | 10.3% H1 FY Aug-2026 | Cardinal | The diagnostic. Guidance is 10.0% full-year. Held at or above 11% across FY Aug-2026 and FY Aug-2027 confirms the structural plateau ; below 9% on a single quarter confirms the cyclical reading and pulls fair value toward ¥1,900. |
| Gross margin | 52.4% H1 FY Aug-2026 | Holding | The pricing-power anchor, rebuilt +5.7pt from the 46.7% trough without volume loss. This is the structural leg of the thesis ; erosion here undoes it. |
| East Asia same-store sales / stock | +23.3% rev · 20.3% margin | Cardinal | 58% of consolidated operating profit on one cyclical market. Same-store sales negative across two quarters, or East Asia stock above sales into a third consecutive quarter, signals a write-down. |
| Inventory days | ~155 days | Watch | The structural liability, up 3.3x over the decade against 3.0x for sales, with ~¥5bn of excess East Asia stock. The first signal of a margin reversal is a markdown. |
| Price-to-book vs corridor | 5.1x | Priced | Decade mean 3.3x, low 1.4x, high 5.65x — a sentiment top, not a mean. The round-trip was 4.4x → 1.4x → 5.1x. Mean-reversion to 3.3x is −34% on the multiple alone. |
| P/E vs peers | 30.7x current-FY | Reference | ~34x on normalised EPS ~106, against MINISO 7.8x, Inditex 25.5x and a decade average of 22.8x. The ~4x gap to MINISO is the core of the de-rating debate. |
| Capital return | 27% payout · zero buyback | Trigger | DPS ¥32 forward, net cash ¥32.8bn, equity ratio 59.7%. A payout toward 40%+ or a first buyback is the only un-priced upside lever ; held at 27% confirms sterilisation. |
| FCF yield | ~2.6% / ~1.9% lease-adj. | Reference | No valuation floor from yield, unlike Shimamura or Pal. The published free-cash conversion is inflated by capitalised leases ; the stock is fully exposed to the margin and multiple. |
The case turns positive if the plateau proves structural rather than cyclical. An operating margin held at or above 11% across the full FY August 2026 and FY August 2027, with East Asia same-store sales staying positive and the stock-to-sales ratio falling, would re-qualify the margin as structural, justify a durable premium, and move the dossier from watchlist to long. A de-rating toward ~¥2,600 — a price-to-book of ~3.7x — would offer the same entry from the other direction. Either is observable ; neither is signalled at the spot.
The case turns negative if the narrow engine stalls. An operating margin falling below 9% on a single quarter, East Asia same-store sales negative across two quarters, or East Asia stock above sales into a third consecutive quarter, would confirm the cyclical reading and engage the mean-reversion of the multiple toward the decade average, resetting fair value toward ¥1,900.
The tail risk is a structural reversal of East Asia demand — a durable loss of brand desirability paired with recurring write-downs — which would take the one engine that carries 58% of the operating profit and convert the bear from a timing disappointment into a permanent impairment, with the floor falling toward ¥1,500 or below. That remains a distribution tail, not the central case, and it is not signalled today.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.